Cargando…

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis

PURPOSE: We conducted a systematic review and meta-analysis to determine the effectiveness and safety of anti-tumor necrosis factor-alpha (TNF-α) agents in the treatment of Behcets’ disease (BD)-associated uveitis. METHOD: Three electronic databases, Embase, MEDLINE, and the Cochrane Library, were s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yunwei, Huang, Zhaohao, Yang, Shizhao, Chen, Xiaoqing, Su, Wenru, Liang, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327708/ https://www.ncbi.nlm.nih.gov/pubmed/32670062 http://dx.doi.org/10.3389/fphar.2020.00941

Ejemplares similares

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
por: Yang, Shizhao, et al.
Publicado: (2021)

Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet’s disease: A systematic review of controlled trials
por: Zhou, Xinwei, et al.
Publicado: (2022)

Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study
por: Qian, Yujing, et al.
Publicado: (2021)

Efficacy and Safety of Anti-Tumor Necrosis Factor-Alpha Agents for Patients with Intestinal Behcet’s Disease: A Systematic Review and Meta-Analysis
por: Zhang, Qingfeng, et al.
Publicado: (2022)

TNF-α in Uveitis: From Bench to Clinic
por: Jiang, Qi, et al.
Publicado: (2021)

Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis
por: Liao, Weiting, et al.
Publicado: (2022)

Corrigendum: TNF-α in Uveitis: From Bench to Clinic
por: Jiang, Qi, et al.
Publicado: (2022)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease
por: Sugita, Sunao, et al.
Publicado: (2012)

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
por: Xiong, Anji, et al.
Publicado: (2021)

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
por: Lee, Ji Hwan, et al.
Publicado: (2018)

Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
por: Celiker, Hande, et al.
Publicado: (2018)

Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Biao, et al.
Publicado: (2021)

Macular involvement in patients with Behçet’s uveitis
por: Kahloun, Rim, et al.
Publicado: (2012)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan
por: Hwang, De-Kuang, et al.
Publicado: (2018)

Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitis
por: Yalçindağ, Fatime Nilüfer, et al.
Publicado: (2013)

Gender Differences in Behçet's Disease Associated Uveitis
por: Ucar-Comlekoglu, Didar, et al.
Publicado: (2014)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
por: Çakar Özdal, Pınar
Publicado: (2020)

Behçet uveitis: Current practice and future perspectives
por: Aboul Naga, Shereen H., et al.
Publicado: (2022)

How challenging can it be to treat Behçet uveitis?
por: Oray, Merih, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

Therapeutic Effects of Upadacitinib on Experimental Autoimmune Uveitis: Insights From Single-Cell Analysis
por: Huang, Zhaohao, et al.
Publicado: (2023)

Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species/TXNIP/HIF-1α axis to alleviate autoimmune uveitis
por: Huang, Jun, et al.
Publicado: (2022)

Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
por: Han, So Jung, et al.
Publicado: (2023)

Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019)

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
por: Fabiani, Claudia, et al.
Publicado: (2019)

Uveitis developing in tuberculous lymphadenitis‐associated Behçet's disease during anti‐tuberculosis therapy
por: Takahashi, Saeko, et al.
Publicado: (2020)

P03-009 - Experiences of in pediatric Behçet uveitis
por: Sozeri, B, et al.
Publicado: (2013)

Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
por: Abd El Latif, Eiman, et al.
Publicado: (2020)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
por: Gueudry, Julie, et al.
Publicado: (2021)

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
por: Park, Jihye, et al.
Publicado: (2018)

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
por: Huang, Mao-Xin, et al.
Publicado: (2021)

The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
por: Lee, Suhwan, et al.
Publicado: (2019)

Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking
por: Bai, Liang Liang, et al.
Publicado: (2021)

Evaluation of factors for predicting risk of uveitis recurrence in Behcet's disease patients
por: Cai, Jianfei, et al.
Publicado: (2020)

Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials
por: Feng, Haihuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_an6p2qhnhk8h75aee3kc15jf1b